Astana Biomed Group, an authorized Abcam distributor in Central Asia

Metabolism

NLG919, small molecule IDO pathway inhibitor (ab231505)

Description:
Potent, small molecule IDO pathway inhibitor
Application:
Reactivity:
Conjugate:

Ozagrel hydrochloride, thromboxane (TXA2) synthetase inhibitor (ab142740)

Description:
Potent and selective thromboxane (TXA2) synthetase inhibitor
Application:
Reactivity:
Conjugate:

Phlorizin, SGLT inhibitor (ab143144)

Description:
Potent, competitive SGLT inhibitor
Application:
Reactivity:
Conjugate:

Prostaglandin A2, Endogenous metabolite (ab120879)

Description:
Endogenous metabolite derived from arachidonic acid
Application:
Reactivity:
Conjugate:

Prostaglandin D2, HDP1 and CRTH2 receptor agonist (ab120888)

Description:
High affinity DP1 and CRTH2 receptor agonist. Major prostaglandin produced by mast cells.
Application:
Reactivity:
Conjugate:

Prostaglandin H2, prostanoid (ab120910)

Description:
Major prostanoid; important precursor in eicosanoid synthesis
Application:
Reactivity:
Conjugate:

Reduced Glutathione (GSH), Endogenous antioxidant (ab142044)

Description:
Endogenous antioxidant
Application:
Reactivity:
Conjugate:

Ro 61-8048, kynurenine 3-monooxygenase (KMO) inhibitor (ab141466)

Description:
Potent, competitive kynurenine 3-monooxygenase (KMO) inhibitor
Application:
Reactivity:
Conjugate:

SC-51089, EP1 receptor antagonist (ab141739)

Description:
Selective EP1 receptor antagonist
Application:
Reactivity:
Conjugate:

SCD1 Inhibitor (DMSO solution), SCD1(stearoyl-CoA desaturase 1) inhibitor (ab146620)

Description:
Potent, selective SCD1(stearoyl-CoA desaturase 1) inhibitor
Application:
Reactivity:
Conjugate:
© 2021 Astana Biomed Group LLP. All rights reserved.